US2018326118A1PendingUtilityA1

Immobilised biological entities

59
Assignee: CARMEDA ABPriority: Sep 15, 2008Filed: Jul 23, 2018Published: Nov 15, 2018
Est. expirySep 15, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61L 2300/42A61L 27/34A61P 7/02A61L 33/068A61L 33/08A61L 33/0035A61L 33/0029A61L 27/54A61L 2300/608A61L 2400/04A61L 2300/236A61L 33/0076
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which entity is covalently attached to said surface through a link comprising a 1,2,3-triazole.

Claims

exact text as granted — not AI-modified
1 - 38 . (canceled) 
     
     
         39 . A heparin moiety capable of interacting with mammalian blood to prevent coagulation or thrombus formation which entity carries an alkyne or an azido group, which alkyne or azido group is attached to a linker, wherein the linker is end-point attached to the heparin moiety. 
     
     
         40 . A heparin moiety according to claim  38  which is a full length heparin. 
     
     
         41 . A heparin moiety according to claim  38  wherein the heparin moiety is covalently end-point attached through position C1 of the reducing terminal to the linker.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.